BERGEN, Norway, May 12, 2016 -- On 11 May 2016 Framar AS (Framar) and Profond AS (Profond), two companies owned by Marine Harvest ASA's Chairman Ole-Eirik Lerøy, sold in total 1,122,000 shares in Marine Harvest. Framar sold 1,000,000 shares in Marine Harvest at a price of NOK 129.90 per share and Profond sold 122,000 shares in Marine Harvest at a price of NOK 129.90 per share. Subsequent to these transactions Ole-Eirik Lerøy and his affiliates hold 2,100,000 shares in Marine Harvest corresponding to 0.47% of the issued share capital.
On 11 May 2016 Alf-Helge Aarskog, CEO in Marine Harvest ASA, sold 100,000 shares in Marine Harvest at a price of NOK 131.11 per share. Subsequent to this transaction Alf-Helge Aarskog holds the following shares and unexercised options in Marine Harvest:
| Shares | Option allotments | |||
| 2013 | 2014 | 2015 | Total | |
| 38 570 | 615 006 | 545 152 | 518 373 | 1 678 531 |
This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.
CONTACT:
Ivan Vindheim, CFO, Mobile: +47 958 71 310
Kim Galtung Døsvig, IR Officer & Head of Treasury, Mobile: +47 908 76 339
HUG#2012017


Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 



